111 related articles for article (PubMed ID: 875465)
1. Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients.
Velasco M; McNay JL
Mayo Clin Proc; 1977 Jul; 52(7):430-2. PubMed ID: 875465
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
Velasco M; Gilbert CA; Rutledge CO; McNay JL
Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
[TBL] [Abstract][Full Text] [Related]
3. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
O'Malley K; Velasco M; Wells J; McNay JL
J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
[TBL] [Abstract][Full Text] [Related]
4. Observation on the mechanism of renin release by hydralazine in hypertensive patients.
Ueda H; Kaneko Y; Takeda T; Ikeda T; Yagi S
Circ Res; 1970 Oct; 27():Suppl 2:201-6. PubMed ID: 4918551
[No Abstract] [Full Text] [Related]
5. Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
Chrysant SG; Adamopoulos P; Tsuchiya M; Frohlich ED
Am Heart J; 1976 Sep; 92(3):335-9. PubMed ID: 782220
[TBL] [Abstract][Full Text] [Related]
6. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
Siitonen L
J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
[TBL] [Abstract][Full Text] [Related]
7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
9. Hydralazine and plasma renin activity.
Ueda H; Yagi S; Kaneko Y
Arch Intern Med; 1968 Nov; 122(5):387-91. PubMed ID: 5687924
[No Abstract] [Full Text] [Related]
10. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
[TBL] [Abstract][Full Text] [Related]
11. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
12. Differential blockade of alpha-adrenoceptors by indoramin.
Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
[TBL] [Abstract][Full Text] [Related]
13. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
Campbell WB; Graham RM; Jackson EK
J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
[TBL] [Abstract][Full Text] [Related]
14. Propranolol-hydralazine combination in essential hypertension.
Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
Ando K; Noda H; Ogata E; Fujita T
J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
[TBL] [Abstract][Full Text] [Related]
16. [Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension: the effect of atenolol (author's transl)].
Philipp T; Cordes U; Distler A
Dtsch Med Wochenschr; 1977 Apr; 102(15):569-74. PubMed ID: 14816
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of hydralazine and alpha- or beta-adrenergic blockers: the role of plasma renin activity.
Gutkin M; Das B; Chin BK; Mezey K; Modlinger RS
J Clin Pharmacol; 1977; 17(8-9):509-18. PubMed ID: 893737
[TBL] [Abstract][Full Text] [Related]
18. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1984; 6(3):392-8. PubMed ID: 6202963
[TBL] [Abstract][Full Text] [Related]
19. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia.
Lewandowski J; Siński M; Bidiuk J; Abramczyk P; Dobosiewicz A; Ciarka A; Gaciong Z
Hypertens Res; 2010 Oct; 33(10):1038-43. PubMed ID: 20668455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
